LSV Asset Management
RIGL icon

LSV Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

LSV Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2M Buy
721,666
+120,159
+20% +$3.71M 0.05% 307
2026
Q1 		$16.3M Buy
601,507
+57,225
+11% +$1.92M 0.04% 337
2025
Q4 		$23.3M Buy
544,282
+433,382
+391% +$16.3M 0.05% 305
2025
Q3 		$3.14M Buy
110,900
+15,200
+16% +$455K 0.01% 525
2025
Q2 		$1.79M Buy
+95,700
New +$1.81M ﹤0.01% 567

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

LSV Asset Management's RIGL Position: Q2 2026 in Review

LSV Asset Management increased its Rigel Pharmaceuticals (RIGL) stake by 20% in Q2 2026, buying an estimated $3.71M and bringing the position to 721,666 shares worth $28.2M. The position accounts for 0.05% of the portfolio, ranked #307.

LSV Asset Management first reported a position in RIGL in Q2 2025 and has held it in 5 quarters since. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • LSV Asset Management held 721,666 shares of Rigel Pharmaceuticals worth $28.2M as of Q2 2026.
  • LSV Asset Management bought 120,159 Rigel Pharmaceuticals shares in Q2 2026, an estimated $3.71M.
  • Rigel Pharmaceuticals made up 0.05% of LSV Asset Management's portfolio in Q2 2026, its #307 holding.
  • LSV Asset Management first reported a position in Rigel Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.